
    
      The objective of this study is to demonstrate arthroscopic surgical treatment of high-grade
      (>50%) partial-thickness tears using REGENETEN yields statistically superior patient
      post-operative recovery outcomes, faster return to activities of daily living, and less
      health care utilization versus standard surgical repair techniques.
    
  